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Abstract
Objectives: Since diastolic abnormalities are typical findings of cardiac
amyloidosis (CA), we hypothesized that speckle-tracking-imaging (STI) derived
longitudinal early diastolic strain rate (LSRdias) could predict outcome in CA patients
with preserved left ventricular ejection fraction (LVEF .50%).
Background: Diastolic abnormalities including altered early filling are typical
findings and are related to outcome in CA patients. Reduced longitudinal systolic
strain (LSsys) assessed by STI predicts increased mortality in CA patients. It
remains unknown if LSRdias also related to outcome in these patients.
Methods: Conventional echocardiography and STI were performed in 41 CA
patients with preserved LVEF (25 male; mean age 65¡9 years). Global and
segmental LSsys and LSRdias were obtained in six LV segments from apical 4-
chamber views.
Results: Nineteen (46%) out of 41 CA patients died during a median of 16 months
(quartiles 5–35 months) follow-up. Baseline mitral annular plane systolic excursion
(MAPSE, 6¡2 vs. 8¡3 mm), global LSRdias and basal-septal LSRdias were
significantly lower in non-survivors than in survivors (all p,0.05). NYHA class,
number of non-cardiac organs involved, MAPSE, mid-septal LSsys, global LSRdias,
basal-septal LSRdias and E/LSRdias were the univariable predictors of all-cause
death. Multivariable analysis showed that number of non-cardiac organs involved
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(hazard ratio [HR] 51.96, 95% confidence interval [CI] 1.17–3.26, P50.010), global
LSRdias (HR57.30, 95% CI 2.08–25.65, P50.002), and E/LSRdias (HR52.98, 95%
CI 1.54–5.79, P50.001) remained independently predictive of increased mortality
risk. The prognostic performance of global LSRdias was optimal at a cutoff value of
0.85 S21 (sensitivity 68%, specificity 67%). Global LSRdias ,0.85 S
21 predicted a
4-fold increased mortality in CA patients with preserved LVEF.
Conclusions: STI-derived early diastolic strain rate is a powerful independent
predictor of survival in CA patients with preserved LVEF.
Introduction
Systemic amyloidosis is an uncommon multisystem disease caused by the
deposition of insoluble proteins in various tissues and organs. Patients with
primary light-chain (AL) amyloidosis have a very poor prognosis with a median
survival of 13 months from diagnosis [1]. Cardiac involvement, termed cardiac
amyloidosis (CA), is observed in about 50% of patients with systemic amyloidosis,
and the major driver of mortality in patients with AL amyloidosis [2, 3].
The optimal diagnostic workup for patients with suspected CA includes a
combination of medical history, cardiac imaging (echocardiography, cardiac
magnetic resonance imaging), electrocardiography, and histopathological exam-
ination (endomyocardial biopsy). Echocardiography is routinely used to detect
cardiac abnormalities in suspected CA. The echocardiographic features of
advanced CA include concentric left ventricular (LV) and right ventricular (RV)
wall thickening, biatrial enlargement, granular sparkling pattern of myocardium,
and diastolic dysfunction [4–6]. Detection of subclinical myocardial dysfunction
in CA is crucial for improving therapy efficiency and predicting prognosis [7, 8].
Further insights into CA can be gained by speckle tracking derived strain rate
imaging (STI), which provides more detailed information on regional myocardial
deformation than conventional echocardiography. Recent studies demonstrated
that longitudinal systolic dysfunction detected by STI was a typical feature of CA
[9–12] and contributed to risk stratification in CA [11].
Diastolic abnormalities are generally recognized as the earliest manifestation of
CA [13, 14] and Doppler-derived LV diastolic filling variables could predict
cardiac mortality risk in CA patients [15]. A newly published study reported that
early diastolic strain rate, a novel marker related to LV filling pressure, was
associated with heart failure and prognosis in acute myocardial infarction patients
[16]. The prognostic value of diastolic strain rate patterns in patients with CA is
still unknown. The purpose of this study was to explore the predictive value of
STI-derived longitudinal early diastolic strain rate (LSRdias) on mortality risk in
CA patients with preserved left ventricular ejection fraction (LVEF).
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Methods
Ethics Statement
Written informed consent was obtained from all patients or their guardians. The
study was approved by Local Ethics Committee at the University of Wu¨rzburg and
conducted in accordance to the Declaration of Helsinki.
Study population
Forty-one patients with biopsy-proven systemic AL amyloidosis and typical
echocardiographic features of cardiac involvement [11] referred to University
Hospital of Wu¨rzburg were included retrospectively. For inclusion, at least one
biopsy specimen from endomyocardial tissue, bone marrow, rectum, kidney, or
subcutaneous fat had to be positive for Congo red staining visualized amyloid.
Non-cardiac, organ involvement was defined according to the guidelines of AL
[17]. Patients with coronary artery disease, more than mild concomitant valvular
disease, moderate to severe arterial hypertension, and hypertrophic cardiomyo-
pathies were excluded. Written informed consent was obtained from all patients
or their guardians. The study was approved by Local Ethics Committee at the
University of Wu¨rzburg and conducted in accordance to the Declaration of
Helsinki.
Electrocardiography
A standard 12-lead electrocardiography was recorded. Low QRS voltage was
defined as peak to peak QRS amplitudes in each limb lead of less than 0.5 mV,
and less than 1.0 mV in any precordial lead [18]. A pseudoinfarct pattern was
defined as a QS wave pattern in 2 contiguous leads in the absence of previous
myocardial infarction.
Echocardiography
A standard transthoracic echocardiography was performed (GE, Vingmed Vivid 7,
Horten, Norway). All measurements were performed offline in a remote
workstation (EchoPAC version 112, GE, Horten, Norway) by a single experienced
operator (DL). Standard two-dimensional (2D) images and Doppler recordings
were obtained according to guidelines [19]. LV end-diastolic (LVEDD), end-
systolic dimensions (LVESD), end-diastolic thickness of the posterior wall
(LVPWd) and the septum (IVSd), LV stroke volume (Teich) and fractional
shortening (Teich) were measured using standard M-mode in parasternal LV long
axis views. From the apical 4-chamber view, RV end-diastolic dimension and end-
systolic right atrial area were measured. RV free wall basal thickness was measured
at end-diastole by M-mode or 2D echocardiography from the subcostal view. Left
atrial end-systolic diameter was measured in 2D mode from the parasternal long-
axis view. LVEF was measured with the biplane Simpson method in apical 4- and
2-chamber views. Average mitral annular plane systolic excursion (MAPSE)
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measured at the septal and lateral sites as well as tricuspid plane annular systolic
excursion were obtained by M-mode in an apical 4-chamber view. LV mass,
indexed to body surface area, (LVMI) was estimated by LV cavity dimension and
wall thickness at end diastole [19]: LV mass (g)50.86[1.046(LVEDD + LVPWd
+ IVSd)3 – LVEDD3)] +0.6.
Pulsed-wave Doppler was performed in the apical 4-chamber view to obtain
mitral inflow velocities for LV filling pattern evaluation. Peak velocity of early (E)
and atrial (A) diastolic filling and deceleration time of E wave (DT) and
isovolumic relaxation time (IVRT) were measured as well as the E/A ratio was
calculated. Tissue Doppler early diastolic mitral annular velocity (E9) was acquired
at the septal annular site. Diastolic function was graded according to recent
guidelines [20] and not graded in patients with atrial fibrillation (n56).
STI-derived systolic and diastolic deformation
STI was analyzed off-line using EchoPAC software (version 112, GE, Horten,
Norway). All 2D grey scale images of standard apical 4-chamber view were
recorded with a frame rate of 50 to 80 frames per second. A region of interest was
created by manually outlining the endocardial border at end-systolic frame on the
apical 4-chamber view. The system automatically tracked the tissue within the
region and divided the myocardium into six segments. Longitudinal strain rate
and strain curves were obtained, and longitudinal peak systolic (LSRsys) and early
diastolic (LSRdias) strain rate as well as peak systolic strain (LSsys) were measured
in the basal, mid, and apical segments of septal and lateral walls. Global LSRsys,
LSRdias and LSsys of all six segments were calculated (Fig. 1). The E/LSRdias ratio
was calculated as the E velocity divided by the global LSRdias.
Reproducibility of LSRsys, LSsys, and LSRdias was assessed by repeated
measurements in the same recordings. Intra-observer variation was assessed by
repeated analysis of 20 randomly selected subjects and blinded to the initial results
by one investigator (DL). Inter-observer variation was done on the same datasets
by two observers (DL and KH). The intra- and inter-observer variability was
assessed by Bland and Altman analysis and intraclass correlation coefficient.
Primary end point
All patients were followed by clinical visit or telephone interview. The primary end
point was all-cause death.
Statistical analysis
Continuous variables were presented as mean ¡ standard deviation (SD) or
median (quartiles) and categorical variables as percentages. Non-normally
distributed variables were normalized prior to analysis using a natural logarithm
or inverted values. Differences on continuous data between two groups were
compared using a Student t-test after normalization if indicated. Categorical data
Diastolic Strain Rate in Cardiac Amyloidosis
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were compared across groups using a Chi-square test or Fisher’s exact test, as
appropriate.
The optimal cut-off values of deformation variables were derived from receiver
operating characteristic (ROC) analysis by maximizing the sum of the sensitivity
and specificity. Survival curves were calculated by the Kaplan-Meier method, and
compared by log-rank tests. Hazard ratios (HR) with 95% confidence intervals
(CI) were calculated using univariable and multivariable Cox proportional-
hazards regression analysis. The variables with P,0.05 in the univariable analysis
were included in the multivariable models. Independent prognostic factors were
identified by the multivariable Cox models with the backward stepwise method
(likelihood ratio) adjusted for age and gender. Incremental model performance
was assessed by changes in the Chi-square value for the regression models.
Statistical significance was defined as P,0.05. Statistical analysis was performed
using IBM SPSS, version 21 for Windows (SPSS).
Results
Baseline clinical and standard echocardiographic characteristics
Baseline clinical characteristics and electrocardiographic findings were similar
between survivors and non-survivors except that the number of involved organs
was significantly higher in non-survivors than in survivors (P50.017, table 1)
while average MAPSE was significantly lower in non-survivors compared to
survivors (P50.041, table 2).
STI-derived systolic and diastolic deformation characteristics
Among systolic deformation parameters (table 3), mid-septal LSsys tended to be
lower in non-survivors than survivors (P50.052). The typical longitudinal apex-
to-base strain gradient (septal apical to basal longitudinal systolic strain ratio
greater than 2.1) was evidenced in 67.5% CA patients but did not discern between
survivors and non-survivors (62% vs. 74%, P50.427). Diastolic strain rate
analysis showed that global LSRdias and basal-septal LSRdias were significantly
lower in non-survivors than in survivors (both P,0.05).
Reproducibility
Systolic and diastolic deformation parameters in 120 segments were measured for
the intra- and inter-observer variability. Mean differences¡2 SD for LSRsys, LSsys,
and LSRdias were 0.04¡0.48 S
21, 0.66¡5.48%, and 20.01¡0.58 S21 for intra-
Fig. 1. Examples for the measurement of longitudinal peak early diastolic strain rate (LSRdias) from two-dimensional speckle tracking imaging. On
the upper panel, solid colored lines indicate corresponding segmental strain rate curves and white dashed line indicates global strain rate curve. The
measurements of longitudinal systolic strain rate (LSRsys) and LSRdias in the basal-septal segment are shown (yellow line) on the lower panel. AVC: aortic
valve closure; MVO: mitral valve opening.
doi:10.1371/journal.pone.0115910.g001
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observer agreement and 0.02¡0.52 S21, 0.36¡5.64%, and 0.04¡0.68 S21 for
inter-observer agreement. Intraclass correlation coefficient for LSRsys, LSsys, and
LSRdias were 0.877 (95% CI 0.831–0.911), 0.907 (95% CI 0.871–0.933), and 0.913
(95% CI 0.880–0.938) for intra-observer reliability and 0.854 (95% CI 0.800–
Table 1. Clinical characteristics and electrocardiographic data.
CA with preserved EF Survivors Non-survivors P value
n541 n522 n519
Age (years) 65¡9 65¡8 65¡11 0.825
Male (n; %) 61% 59% 63% 0.790
BMI (kg/m2) 24¡3 23¡2 24¡4 0.355
Systolic blood pressure (mmHg) 119¡19 122¡17 116¡21 0.354
Diastolic blood pressure (mmHg) 72¡13 75¡12 69¡14 0.203
Heart rate (beats/min) 76¡9 75¡12 77¡9 0.419
NYHA class 2.3¡0.8 2.1¡0.8 2.4¡0.8 0.195
NYHA class III/IV, n (%) 44 33% 55% 0.162
Pleural effusion (%) 43% 37% 50% 0.419
Number of non-cardiac organs involved 1.5¡0.9 1.2¡0.8 1.8¡0.8 0.017
Renal (%) 59% 45% 74% 0.069
Hepatic/gastrointestinal (%) 69% 65% 74% 0.557
Lung (%) 8% 0% 16% 0.106
Neuropathic (%) 5% 5% 5% 1.000
Soft tissues/bone (%) 10% 5% 16% 0.342
Biomarkers
NT-proBNP (pg/mL) 3813 (1546–14564) 1830 (998–21882) 4543 (2846–15193) 0.352
Creatinine (mg/mL) 1.2 (0.8–1.8) 1.1 (0.7–1.9) 1.2 (0.9–1.8) 0.845
GGT (UL) 91 (32–221) 74 (36–226) 111 (29–242) 0.684
AKP (UL) 83 (67–141) 73 (62–95) 90 (68–216) 0.125
Albumin (g/dL) 3.7 (3.0–4.1) 3.7(3.4–4.0) 3.6 (2.8–4.3) 0.756
Free Kappa light chain (mg/L) 21 (6–114) 21 (17–129) 16 (1.5–114) 0.384
Free Lambda light chain (mg/L) 22 (10–122) 12 (9–122) 31 (21–327) 0.082
Kappa/Lambda ratio 1.11 (0.07–8.40) 1.43 (0.327–12.70) 0.45 (0.01–7.84) 0.343
Cardiac-related drug therapy
Beta blocker 43% 50% 35% 0.368
Angiotensin converting enzyme inhibitor 38% 45% 29% 0.330
Diuretics 62% 50% 77% 0.098
Electrocardiography
Unexplained low voltage 50% 50% 50% 1.000
QRS-T wave pseudo-infarct changes 44% 45% 42% 0.855
I/II ˚atrioventricular block 64% 53% 75% 0.188
Left/right bundle branch block 39% 50% 26% 0.129
Non-survivors vs. survivors P,0.05 indicated significantly different. CA: cardiac amyloidosis; BMI: body mass index; NYHA class: New York Heart
Association functional classification; NT-proBNP: N-terminal pro-B-type natriuretic peptide; GGT: Gamma-glutamyl transpeptidase; AKP: alkaline
phosphatase enzyme.
doi:10.1371/journal.pone.0115910.t001
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0.894), 0.903 (95% CI 0.865–0.930), and 0.887 (95% CI 0.844–0.918) for inter-
observer reliability.
Predictive value of systolic and diastolic strain rate for survival
Nineteen patients (46%) died during a median follow-up time of 16 (5–35)
months. As shown in table 4, univariable predictors of all-cause mortality
included NYHA functional class, number of non-cardiac organ involved, MAPSE,
Table 2. Echocardiographic characteristics.
CA with preserved EF Survivors Non-survivors
P
value
n541 n522 n519
Cardiac size
LV end-diastolic dimension (mm) 43¡6 42¡6 43¡7 0.625
LV end-systolic dimension (mm) 29¡5 29¡5 29¡6 0.802
IVS thickness (mm) 15¡3 14¡3 15¡3 0.557
LV posterior wall thickness (mm) 14¡3 14¡3 15¡2 0.333
RV dimension (mm) 34¡5 33¡5 36¡5 0.104
RV lateral wall thickness (mm) 6¡1 6¡1 6¡1 0.647
Relative wall thickness 0.68¡0.17 0.67¡0.18 0.70¡0.17 0.542
LA diameter (mm) 42¡7 41¡7 43¡6 0.350
RA area (cm2) 18¡5 17¡5 20¡5 0.140
LVMI (g/m2) 138¡47 130¡47 145¡47 0.304
LV/RV Systolic function
LV fractional shortening (%) 31¡7 31¡7 30¡7 0.652
LV EF (%) 62¡6 62¡6 61¡6 0.872
Stroke volume (ml) 46¡17 42¡18 50¡14 0.140
MAPSE (mm) 7¡3 8¡3 6¡2 0.041
TAPSE (mm) 15¡4 16¡5 14¡4 0.203
LV diastolic function
E wave (m/s) 0.87¡0.24 0.86¡0.26 0.88¡0.22 0.841
E/A 1.46¡0.88 1.31¡0.81 1.62¡0.95 0.307
E/E9 20¡9 19¡8 21¡10 0.456
DT (ms) 176¡62 184¡67 167¡57 0.377
IVRT (ms) 89¡19 89¡18 88¡20 0.844
Diastolic filling pattern:
Normal/abnormal relaxation/pseudonormal/restrictive/atrial fibrillation 1/17/9/8/6 1/10/4/3/4 0/7/5/5/2 0.549
SPAP (mmHg) 38¡15 36¡14 39¡16 0.507
Pericardial effusion 49% 50% 47% 0.867
Myocardial sparkling texture 85% 86% 84% 1.000
Non-survivors vs. survivors P,0.05 indicated significantly different. LV: left ventricle; RV: right ventricle; LA: left atrium; RA: right atrium; IVS: interventricular
septum; LVMI: LV mass indexed to body surface area; EF: ejection fraction; MAPSE: average of mitral annular plane systolic excursion measured at the
septal and lateral sites; TAPSE: tricuspid annular plane systolic excursion; E: early diastolic peak filling velocity; A: late diastolic peak filling velocity; E9:
tissue Doppler early diastolic septal mitral annular velocity. DT: deceleration time of early diastolic peak velocity; IVRT: isovolumic relaxation time; SPAP:
systolic pulmonary artery pressure.
doi:10.1371/journal.pone.0115910.t002
Diastolic Strain Rate in Cardiac Amyloidosis
PLOS ONE | DOI:10.1371/journal.pone.0115910 December 26, 2014 8 / 17
mid-septal LSsys, global LSRdias, basal-septal LSRdias and E/LSRdias (all P,0.05).
Table 5 showed the correlations among the deformation parameters, suggesting
that E/LSRdias was closely related to global LSRdias (R520.712). Therefore, E/
LSRdias and global LSRdias were respectively added into two multivariable models
(table 6, Model A and B). Multivariable analysis showed that number of non-
cardiac organs involved (HR51.96, 95% CI 1.17–3.26, P50.010), global LSRdias
(HR57.30, 95% CI 2.08–25.65, P50.002), and E/LSRdias (HR52.98, 95% CI
1.54–5.79, P50.001) remained independently predictive of increased mortality
risk (table 6).
ROC analysis showed global LSRdias outperformed conventional diastolic
parameters (E9 and E/E9) as well as E/LSRdias for predicting mortality in this
Table 3. Longitudinal systolic and diastolic strain rate and strain.
Survivors Non-survivors P value
n522 n519
Global LSsys (%) 213¡4 211¡3 0.143
Global LSRsys (S
21) 20.8¡0.3 20.8¡0.2 0.603
Global LSRdias (S
21) 0.97¡0.30 0.76¡0.26 0.024
E/LSRdias 0.97¡0.33 1.36¡0.84 0.057
Segmental LSsys (%)
Apical septal 219¡6 217¡6 0.339
Mid septal 212¡5 29¡4 0.052
Basal septal 28¡5 26¡3 0.086
Apical lateral 217¡5 217¡6 0.638
Mid lateral 211¡4 210¡4 0.398
Basal lateral 28¡5 27¡4 0.383
Septal LSsysapi/bas 3.0¡2.0 3.5¡1.7 0.447
Segmental LSRsys (S
21)
Apical septal 21.3¡0.5 21.4¡0.5 0.533
Mid septal 20.7¡0.3 20.6¡0.3 0.209
Basal septal 20.5¡0.3 20.4¡0.2 0.223
Apical lateral 21.3¡0.5 21.3¡0.3 0.848
Mid lateral 20.9¡0.4 20.8¡0.2 0.219
Basal lateral 20.8¡0.4 20.6¡0.2 0.228
Segmental LSRdias (S
21)
Apical septal 1.6¡0.6 1.5¡0.6 0.601
Mid septal 0.8¡0.3 0.6¡0.3 0.103
Basal septal 0.6¡0.4 0.4¡0.2 0.015
Apical lateral 1.6¡0.7 1.6¡0.6 0.974
Mid lateral 1.1¡0.5 0.9¡0.4 0.269
Basal lateral 0.9¡0.6 0.6¡0.5 0.056
Non-survivors vs. survivors P,0.05 indicated significantly different. LSsys: longitudinal peak systolic strain; LSRsys: longitudinal peak systolic strain rate;
LSRdias: longitudinal peak early diastolic strain rate; E/LSRdias: early diastolic peak filling velocity to global LSRdias ratio; LSsysapi/bas: septal apical to basal
longitudinal systolic strain ratio.
doi:10.1371/journal.pone.0115910.t003
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cohort (Fig. 2 left). The prognostic performance of global LSRdias was optimal at a
cutoff value of 0.85 S21 (sensitivity 68%, specificity 67%, positive predictive value
65%, and negative predictive value 70%). CA Patients with global LSRdias
,0.85 S21 was related with a 4-fold increase of all-cause mortality than those with
global LSRdias $0.85 S
21 (Fig. 2 right).
Incremental predictive power of STI information
Clinical variables (Model I) including age, NYHA class and number of involved
organs were entered in the first step of a multivariable Cox model are predictive of
mortality (Chi-square 6.74, P50.012). In Model II, adding conventional
echocardiographic parameters (MAPSE and E/E9) to Model I enhanced the
explanatory power (Chi-square 14.83, P50.009 vs. Model I). Adding global
LSRdias (Model III) further improved the prognostic performance (Chi-square
20.47, P50.020 vs. Model II; Fig. 3).
Table 4. Prediction for Mortality by univariable Cox proportional hazard regression analysis.
Hazard ratio (95% CI) P value
Age (years) 0.98 (0.93–1.02) 0.338
Male 0.80 (0.31–2.04) 0.638
NYHA class 1.77 (1.02–3.09) 0.044
Number of non-cardiac involved organs 2.00 (1.15–3.46) 0.014
LVMI (g/m2) 1.00 (0.99–1.01) 0.401
LAD (mm) 1.03 (0.97–1.10) 0.331
MAPSE (mm) 1.24 (1.02–1.50) 0.034
DT (ms) 0.99 (0.98–1.00) 0.069
E/E9 1.05 (0.99–1.10) 0.091
Global LSsys (%) 2.30 (0.88–6.03) 0.097
Septal LSsysapi/bas 1.09 (0.91–1.31) 0.339
Mid-septal LSsys (%) 1.10 (1.01–1.22) 0.027
Global LSRdias (S
21) 4.90 (1.73–13.89) 0.003
Basal-septal LSRdias (S
21) 3.14 (1.53–6.45) 0.002
E/LSRdias 3.27 (1.70–6.29) ,0.001
CI: confidence interval. For abbreviations, see table 2 and 3.
doi:10.1371/journal.pone.0115910.t004
Table 5. Spearman’s Correlations among deformation parameters.
E/LSRdias Mid-septal LSsys Basal-septal LSRdias Global LSRdias
E/LSRdias 1 0.576 (P,0.001) 20.358 (P50.023) 20.721 (P,0.001)
Mid-septal LSsys 0.576 (P,0.001) 1 20.535 (P,0.001) 20.503 (P50.001)
Basal-septal LSRdias 20.358 (P50.023) 20.535 (P,0.001) 1 0.292 (P50.068)
Global LSRdias 20.721 (P,0.001) 20.445 (P50.004) 0.292(P50.068) 1
doi:10.1371/journal.pone.0115910.t005
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Discussion
This is the first attempt to explore the prognostic value of STI-derived global
LSRdias for predicting overall mortality risk in CA patients with preserved LVEF.
We found that global LSRdias was superior to conventional diastolic parameters
(E9 and E/E9) for predicting outcome and improved the risk stratification in CA
patients with preserved LVEF(.50%). Reduced global LSRdias (,0.85 S
21)
independently predicted a 4-fold increased mortality in these patients, while mid-
septal LSsys only showed borderline significance (P50.052) on outcome. Adding
global LSRdias to clinical data and conventional echocardiographic variables
offered incremental prognostic value.
Table 6. Multivariable Cox proportional hazard regression analysis.
Model A Hazard ratio (95% CI) P value Model B Hazard ratio (95% CI)
P
value
NYHA class 1.56 (0.89–2.74) 0.122 NYHA class 1.55 (0.89–2.71) 0.122
Number of non-cardiac organs involved 1.96 (1.17–3.26) 0.010 Number of non-cardiac organs involved 1.72 (1.00–2.99) 0.052
MAPSE (mm) 1.15 (0.96–1.38) 0.137 MAPSE (mm) 1.15 (0.96–1.38) 0.137
Mid-septal LSsys (%) 1.00 (0.87–1.14) 0.946 Mid-septal LSsys (%) 1.01 (0.89–1.14) 0.878
Basal-septal LSRdias (S
21) 1.88 (0.78–4.52) 0.158 Basal-septal LSRdias (S
21) 1.72 (0.60–4.97) 0.311
Global LSRdias (S
21) 7.30 (2.08–25.65) 0.002 E/LSRdias 2.98 (1.54–5.79) 0.001
Adjusted for age and gender with a backward stepwise method (likelihood ratio). For abbreviations, see table 2 and 3.
doi:10.1371/journal.pone.0115910.t006
Fig. 2. The receiver operating characteristic (ROC) analysis of global early diastolic strain rate (LSRdias) for predicting mortality (left) and
cumulative survival stratified by the optimal cut-off value for global LSRdias (right). Global LSRdias serves as the best marker for predicting mortality in
cardiac amyloidosis patients with preserved ejection fraction (area under of ROC curve: 0.72 (0.56–0.89), P50.019). CA Patients with global LSRdias
,0.85 S21 suggests about 4-fold increase of all-cause mortality than those with preserved global LSRdias value.
doi:10.1371/journal.pone.0115910.g002
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Systolic and diastolic functions and outcome in CA patients with
preserved LVEF
It was shown that LV wall thickening and reduced LVEF are associated with
higher mortality risk in CA patients [2]. In the present study, we compared the
prognostic values of traditional and advanced echocardiographic parameters in a
small subset of CA patients with preserved systolic function and similar LV wall
thickness. Our results showed that, MAPSE, a simple classic parameter reflecting
longitudinal LV function [21], was significantly lower in non-survivor group,
suggesting longitudinal dysfunction was associated with poor outcome in CA
patients with preserved LVEF. Recent studies reported the diagnostic and
prognostic value of two- or three-dimensional STI derived strain and strain rate in
various cardiovascular diseases [22, 23]. Bellavia et al. demonstrated that reduced
global and basal longitudinal systolic strains were independently linked with
increased all-cause mortality in AL amyloidosis patients [24, 25]. We, and other
groups, recently also showed that an intra-wall longitudinal systolic strain
gradient with preserved LSsys at apical segments and significantly reduced LSsys at
mid and basal segments is a typical strain pattern for CA [9–11]. In the current
cohort, reduction in longitudinal systolic strain at mid segments of the septum
(mid-septal LSsys) was evidenced and associated with increased mortality. But
MAPSE and mid-septal LSsys are only univariable but not independent predictors
of all-cause mortality. The reason for the non-independent predictive value of
Fig. 3. Incremental model performance for predicting prognosis assessed by starting with the clinical
variables (Model I: age, NYHA class, and number of non-cardiac organs involved), followed by the
conventional echocardiographic parameters (Model II: adding MAPSE and E/E9 to model I), and finally
by adding advanced global LSRdias (Model III). MAPSE: mitral annular plane systolic excursion; E/E9: early
diastolic peak filling velocity to tissue Doppler early diastolic septal mitral annular velocity ratio. LSRdias:
longitudinal peak early diastolic strain rate.
doi:10.1371/journal.pone.0115910.g003
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MAPSE and mid-septal LSsys might originate from the fact that LVEF was
preserved and by nature related to a better systolic function in our cohort.
Diastolic abnormalities are typical features of CA and related to the degree of
amyloid infiltration in heart, LV compliance becomes increasingly reduced
resulting in a ‘‘stiff ventricle’’ with increasing myocardial amyloid infiltration
[13, 14]. Early CA typically presents with a mildly increased wall thickness and an
abnormal relaxation filling pattern, while advanced CA shows a grossly increased
wall thickness and a restrictive filling pattern with markedly shortened
deceleration time and a low velocity A wave [26, 27]. Pulsed tissue Doppler (E9)
was useful to detect early myocardial diastolic impairment, and the E/E9 ratio was
related to increased LV filling pressure [28]. Consistent with these findings, 34 out
of 35 (97%) CA patients with sinus rhythm showed various degrees of diastolic
filling abnormalities (relaxation abnormal 48%, pseudonormal 23%, restrictive
17%) and 72% patients had E/E9.15 in our cohort. Wang et al. demonstrated
that global strain rate during the isovolumetric relaxation period (SRIVR) derived
by STI is strongly related to hemodynamic indices of LV relaxation both in an
animal model and in patients, and E/SRIVR can predict LV filling pressures,
particularly in patients with normal ejection fraction [29]. However, Kasner et al.
revealed only a weak correlation of SRIVR with LV stiffness coefficient in heart
failure patients with normal ejection fraction by a simultaneous comparison
during invasive conductance catheterization [30]. In our study, global SRIVR was
not quantified as with speckle tracking imaging the temporal resolution is not
good enough for the detection of change of deformation during this short period.
Thus, only global and segmental strain rate during early LV filling were assessed.
The study by Wang et al. also reported that strain rate during early LV filling (i.e.
SRdias) was negatively correlated to tau (r520.56) and pulmonary capillary wedge
pressure (r520.46) in humans, although this association was weaker than that of
SRIVR [29]. Kasner et al. showed that despite there was a reasonable correlation
between STI derived diastolic parameters (SRdias, SRIVR, E/SRdias, E/SRIVR) and LV
relaxation, strain rate imaging is not superior in diagnosing diastolic dysfunction
in patients with preserved EF as compared with established tissue Doppler
parameter E/E9 [30]. Different from aforementioned studies, present study
focused on the relationship of early diastolic strain rate with the outcome of CA
patients. Our data showed that global LSRdias and E/LSRdias remained
independent predictor of mortality in these patients. Moreover, ROC analysis
showed global LSRdias outperformed conventional diastolic parameters (E9, E/E9,
and E/LSRdias) for predicting mortality in this cohort. In a previous study, Kim et
al. reported that LSRdias was related with LV geometric remodeling patterns in
hypertensive subjects, and the lowest LSRdias value was evidenced in patients with
concentric hypertrophy [31]. It is therefore not surprising that significantly
reduced LSRdias was detected in CA patients with preserved LVEF since concentric
hypertrophy is one typical pathological feature of these patients. Our study
extends previous findings by demonstrating that LSRdias is not only reduced but
also a prognostic marker for poor outcome in CA patients with preserved EF,
superior to other diastolic parameters.
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Incremental predictive power of STI information
When focusing on prognosis in CA, three different aspects should be evaluated: 1)
Clinical symptoms, 2) general organ involvement, and 3) cardiac stage of disease
progression. In our cohort, NYHA class and number of non-cardiac organs
involved were related to increased mortality.
Kristen et al. found that NYHA class was a risk factor but number of organs
involved (including heart) was not associated with increased mortality in AL
patients [32]. The underlying reason might be associated with the patient
selection, every patient had cardiac involvement because of the inclusion criteria
and CA patients have a much higher mortality risk, and involvement of other
non-cardiac organs seems to be an additional risk factor for death as shown in CA
patients of this cohort.
Our results showed that entering clinical variables including age, NYHA class
and number of involved organs in the multivariable Cox regression model are
predictive of mortality (Model I, P50.012). Adding conventional echocardio-
graphic parameters (MAPSE and E/E9) to Model I (Model II) enhanced the
explanatory power (P50.009 vs. Model I). Adding global LSRdias (Model III)
further improved the prognostic performance (P50.020 vs. Model II). Thus, on
top of clinical profile and conventional echocardiographic markers, a reduction in
global LSRdias serves as an independent and incremental risk predictor of all-cause
death in CA patients with preserved LVEF.
Study limitations
The sample size was relatively small in this study. Future studies with larger
patient cohort are warranted to verify the finding in the present study and to
compare early diastolic strain rate changes between patients with light chain
amyloidosis and non-light chain amyloidosis. Recent studies showed that high
sensitive cardiac troponin-T might play an important role for the assessment of
prognosis in AL amyloidosis [8, 32, 33]. Due to the retrospective feature of this
study, there were few data on high sensitive cardiac troponin-T in this cohort.
Thus, further prospective conducted studies are necessary to analyze the
additional prognostic performance of high sensitive cardiac biomarkers in CA
patients with preserved LVEF.
In addition, rapid early diastolic untwist in normal hearts servers as an
important component of diastolic suction, and it could be diminished in the
earliest stages of diastolic dysfunction [34]. Experimental studies have shown that
LV twist at end systole and at end diastole is linearly related to volume, and this
relationship is independent of variations in contractility, afterload, and heart rate
[35]. Previous study found that STI-derived apical diastolic untwist was
significantly correlated to established echocardiographic measures of diastolic
function [36]. Further investigation is warranted on the value of STI-derived LV
untwisting for diagnosing diastolic dysfunction and for predicting outcome in
patients with CA.
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Conclusions
Speckle tracking imaging-derived diastolic deformation improves the risk
assessment of CA patients with preserved LVEF. A reduction in global LSRdias
serves as an independent and incremental risk predictor of all-cause death in CA
patients with preserved LVEF.
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